NO864599L - Fremgangsmaate for fremstilling av terapeutisk aktive fenoksyalkarboksylsyrer og estere derav. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive fenoksyalkarboksylsyrer og estere derav.

Info

Publication number
NO864599L
NO864599L NO864599A NO864599A NO864599L NO 864599 L NO864599 L NO 864599L NO 864599 A NO864599 A NO 864599A NO 864599 A NO864599 A NO 864599A NO 864599 L NO864599 L NO 864599L
Authority
NO
Norway
Prior art keywords
compound
group
amino
formula
phenyl
Prior art date
Application number
NO864599A
Other languages
English (en)
Norwegian (no)
Other versions
NO864599D0 (no
Inventor
Peter Hallett
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO864599D0 publication Critical patent/NO864599D0/no
Publication of NO864599L publication Critical patent/NO864599L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
NO864599A 1985-11-19 1986-11-18 Fremgangsmaate for fremstilling av terapeutisk aktive fenoksyalkarboksylsyrer og estere derav. NO864599L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858528398A GB8528398D0 (en) 1985-11-19 1985-11-19 Chemical compounds

Publications (2)

Publication Number Publication Date
NO864599D0 NO864599D0 (no) 1986-11-18
NO864599L true NO864599L (no) 1987-05-20

Family

ID=10588403

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864599A NO864599L (no) 1985-11-19 1986-11-18 Fremgangsmaate for fremstilling av terapeutisk aktive fenoksyalkarboksylsyrer og estere derav.

Country Status (14)

Country Link
EP (1) EP0223593B1 (de)
JP (1) JPS62155250A (de)
KR (1) KR870004950A (de)
AT (1) ATE65992T1 (de)
AU (1) AU593039B2 (de)
DE (1) DE3680753D1 (de)
DK (1) DK550186A (de)
FI (1) FI864692L (de)
GB (2) GB8528398D0 (de)
IL (1) IL80701A0 (de)
NO (1) NO864599L (de)
PH (1) PH23837A (de)
PT (1) PT83762B (de)
ZA (1) ZA868740B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3610643A1 (de) * 1986-03-29 1987-10-01 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeure-derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
DE3642105A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte aminomethyl-5,6,7,8-tetrahydronaphtyl-oxyessigsaeuren, neue zwischenprodukte, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
AT396235B (de) * 1987-02-06 1993-07-26 Tanabe Seiyaku Co Phenoxyessigsaeurederivate und ihre herstellung
GB8708233D0 (en) * 1987-04-07 1987-05-13 Smith Kline French Lab Pharmaceutically active compounds
JPH068274B2 (ja) * 1988-01-19 1994-02-02 田辺製薬株式会社 フェノキシ酢酸誘導体
EP0325245B1 (de) * 1988-01-19 1993-10-20 Tanabe Seiyaku Co., Ltd. Phenoxyessigsäure-Derivate, ihre Herstellung, pharmazeutische Zusammensetzungen, die sie enthalten, und deren Verwendung
JPH068275B2 (ja) * 1988-02-04 1994-02-02 田辺製薬株式会社 フェノキシ酢酸誘導体
DE3821540A1 (de) * 1988-06-25 1989-12-28 Boehringer Mannheim Gmbh Neue sulfonamide, verfahren zu ihrer herstellung sowie solche sulfonamide enthaltende arzneimittel
DE3829431A1 (de) * 1988-08-31 1990-03-01 Boehringer Mannheim Gmbh Sulfonamide mit tetrazolylrest, verfahren zur ihrer herstellung sowie arzneimittel
US5280043A (en) * 1988-10-10 1994-01-18 Smith Kline & French Laboratories Ltd. Sulphonamido containing phenylalkanoic acids as thromboxane A2 antagonists
US5070099A (en) * 1988-10-31 1991-12-03 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same method of use
US4959383A (en) * 1988-10-31 1990-09-25 E. R. Squibb & Sons, Inc. Phenylsulfone alkenoic acids, derivatives thereof, compositions containing same and method of use
US5006542A (en) * 1988-10-31 1991-04-09 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same and method of use
DE3942923A1 (de) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeure-amide, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
DE4031821A1 (de) * 1990-10-08 1992-04-09 Boehringer Mannheim Gmbh Verwendung von thromboxan-a2-rezeptoren-antagonisten gegen proliferative veraenderungen in der gefaesswand
AU688756B2 (en) * 1993-03-17 1998-03-19 Meiji Seika Kabushiki Kaisha Novel compound with platelet aggregation inhibitor activity
WO1999047497A2 (en) * 1998-03-13 1999-09-23 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
US6242493B1 (en) 1998-03-13 2001-06-05 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
JP4879433B2 (ja) * 2000-01-13 2012-02-22 エミスフェアー・テクノロジーズ・インク 活性剤を送達するための化合物および組成物
WO2007008541A2 (en) * 2005-07-08 2007-01-18 Kalypsys, Inc. Cellular cholesterol absorption modifiers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
DE3610643A1 (de) * 1986-03-29 1987-10-01 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeure-derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
FI864692A7 (fi) 1987-05-20
AU6550586A (en) 1987-05-21
DK550186A (da) 1987-05-20
EP0223593A3 (en) 1989-01-18
FI864692A0 (fi) 1986-11-18
EP0223593B1 (de) 1991-08-07
GB2183234A (en) 1987-06-03
GB8528398D0 (en) 1985-12-24
NO864599D0 (no) 1986-11-18
PT83762B (en) 1988-12-07
GB8627512D0 (en) 1986-12-17
JPS62155250A (ja) 1987-07-10
ATE65992T1 (de) 1991-08-15
IL80701A0 (en) 1987-02-27
DE3680753D1 (de) 1991-09-12
KR870004950A (ko) 1987-06-02
ZA868740B (en) 1987-07-29
FI864692L (fi) 1987-05-20
PT83762A (en) 1986-12-01
PH23837A (en) 1989-11-23
GB2183234B (en) 1989-10-04
DK550186D0 (da) 1986-11-18
AU593039B2 (en) 1990-02-01
EP0223593A2 (de) 1987-05-27

Similar Documents

Publication Publication Date Title
NO864599L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenoksyalkarboksylsyrer og estere derav.
FI106857B (fi) Menetelmä uusien farmakologisesti aktiivisten salisyylihappojohdannaisten valmistamiseksi
US7915448B2 (en) Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists
JP4290872B2 (ja) シクロオキシゲナーゼ−２阻害薬としての２，３，５−トリ置換ピリジン類
PL180948B1 (pl) Nowe inhibitory syntazy prostaglandyny i środek farmaceutyczny
EA002740B1 (ru) Производные гуанидина (варианты), способ их получения (варианты), фармацевтическая композиция для ингибирования протеолиза у млекопитающего, способ лечения, способ ингибирования: протеолиза у млекопитающего, тромбин-индуцированной агрегации тромбоцитов и образования сгустков фибриногена в плазме, тромбина в крови, образования агрегатов тромбоцитов в крови, образования тромбов в крови, устройство для сбора, циркуляции и хранения крови
FI87769B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefull fenoxiaettiksyra
AU2002249812A1 (en) Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
EP1406609A2 (de) Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren
CN112601525A (zh) 2,6-二氨基吡啶化合物
US7566739B2 (en) Substituted N-sulfonylaminophenylethyl-2-phenoxyacetamide compounds as VR1 receptor antagonists
EP3810143A1 (de) Nadph-oxidase-inhibitoren, diese enthaltende pharmazeutische zusammensetzung und deren verwendung
JPS6147478A (ja) 新規な生物活性化合物
CN102686574A (zh) 作为具有治疗应用的受体调节剂的香豆素化合物
PT100332B (pt) Agentes para o tratamento de doencas cardiovasculares derivados de piridina e imidazole
PT91783B (pt) Processo para a preparacao de {(diarilmetoxi) alquil}-1-pirrolidinas e piperidinas
US6277839B1 (en) Biphenylene lactams as prostaglandin receptor ligands
US3886167A (en) 2-Aryl-6-trifluoromethyl-4-pyridylcarbinolamine antimalarials
HU182257B (en) Process for producing benzothiazole derivatives and pharmaceutical compositions containing them as active agents
PT770082E (pt) Derivados de acido dioxo-tiopirano-piridinocarboxilico e sua utilizacao como medicamentos
CA1335672C (en) Thioformamide derivatives
JPS63297358A (ja) ジアリールアルキル置換アルキルアミン
CZ20012710A3 (cs) Acetylenické arylové sulfonamidohydroxamové a fosfinamidohydroxamové kyseliny jako inhibitory TACE
WO2014012964A1 (en) New antifibrinolytic compounds
WO2008111794A1 (en) 4-methylimidazol-5-ylcarbonylguanidine derivatives, pharmaceutically acceptable salts thereof, preparation method, and pharmaceutical compositions for the prevention and treatment of the ischemic heart diseases containing the same as an active ingredient